Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2322 | 0.2322 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 1 | 1 |
Loa Loa (eye worm) | SWIB/MDM2 domain-containing protein | 0.0167 | 1 | 1 |
Echinococcus multilocularis | Upstream activation factor subunit UAF30 | 0.0167 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0059 | 0.2322 | 1 |
Mycobacterium ulcerans | cytochrome P450 185A4 Cyp185A4 | 0.0038 | 0.0775 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0059 | 0.2322 | 1 |
Trypanosoma brucei | Zn-finger in Ran binding protein and others/FYVE zinc finger, putative | 0.0059 | 0.2322 | 1 |
Toxoplasma gondii | DNA topoisomerase domain-containing protein | 0.0167 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2322 | 0.2322 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Toxoplasma gondii | SWIB/MDM2 domain-containing protein | 0.0167 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2322 | 0.2322 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0038 | 0.0775 | 0.0775 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0059 | 0.2322 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0059 | 0.2322 | 0.1677 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Trypanosoma cruzi | WLM domain containing protein, putative | 0.0059 | 0.2322 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2322 | 0.2322 |
Echinococcus granulosus | Upstream activation factor subunit UAF30 | 0.0167 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0059 | 0.2322 | 0.2322 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0059 | 0.2322 | 0.1677 |
Chlamydia trachomatis | DNA topoisomerase I | 0.0167 | 1 | 0.5 |
Brugia malayi | SWIB/MDM2 domain containing protein | 0.0167 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0167 | 1 | 1 |
Brugia malayi | brahma associated protein 60 kDa | 0.0167 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Onchocerca volvulus | 0.0167 | 1 | 1 | |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0167 | 1 | 1 |
Plasmodium vivax | SWIB/MDM2 domain-containing protein, putative | 0.0167 | 1 | 0.5 |
Chlamydia trachomatis | SWIB complex protein | 0.0167 | 1 | 0.5 |
Loa Loa (eye worm) | brahma associated protein | 0.0167 | 1 | 1 |
Trypanosoma cruzi | Zn-finger in Ran binding protein and others, putative | 0.0059 | 0.2322 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0167 | 1 | 1 |
Loa Loa (eye worm) | CYP4Cod1 | 0.0038 | 0.0775 | 0.0775 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0167 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0059 | 0.2322 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0167 | 1 | 0.5 |
Trypanosoma brucei | mitochondrial RNA binding complex 1 subunit | 0.0059 | 0.2322 | 1 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0059 | 0.2322 | 0.1677 |
Brugia malayi | YY1-associated factor 2 | 0.0059 | 0.2322 | 0.1677 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0059 | 0.2322 | 1 |
Plasmodium vivax | hypothetical protein, conserved | 0.0167 | 1 | 0.5 |
Echinococcus multilocularis | SWI:SNF matrix associated | 0.0167 | 1 | 1 |
Schistosoma mansoni | brg-1 associated factor | 0.0167 | 1 | 1 |
Trypanosoma cruzi | mitochondrial RNA binding complex 1 subunit, putative | 0.0059 | 0.2322 | 1 |
Loa Loa (eye worm) | cytochrome P450 family protein | 0.0038 | 0.0775 | 0.0775 |
Brugia malayi | Zn-finger in Ran binding protein and others containing protein | 0.0059 | 0.2322 | 0.1677 |
Plasmodium falciparum | SWIB/MDM2 domain-containing protein | 0.0167 | 1 | 1 |
Echinococcus granulosus | SWI:SNF matrix associated | 0.0167 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.1 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against Herpes simplex virus type 1 (F strain) | ChEMBL. | 7932543 |
MIC (functional) | = 0.5 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against Herpes simplex virus type 1 (McIntyre strain) | ChEMBL. | 7932543 |
MIC (functional) | = 2 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against Herpes simplex virus type 2 (196 strain) | ChEMBL. | 7932543 |
MIC (functional) | = 2.1 ug ml-1 | The minimum inhibitory concentration was measured against Herpes simplex virus type 1 (KOS strain) on E6SM cells | ChEMBL. | 7932543 |
MIC (functional) | = 4.5 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against Herpes simplex virus type 2 (G strain) | ChEMBL. | 7932543 |
MIC (functional) | = 13 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against Herpes simplex virus type 2 (Lyons strain) | ChEMBL. | 7932543 |
MIC (functional) | > 50 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against TK-Herpes simplex virus type 1 (B2006 strain) | ChEMBL. | 7932543 |
MIC (functional) | > 50 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (YS strain) | ChEMBL. | 7932543 |
MIC (functional) | > 50 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells against Varicella zoster virus (OKA strain) | ChEMBL. | 7932543 |
MIC (functional) | > 50 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (YS-R strain) | ChEMBL. | 7932543 |
MIC (functional) | > 50 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells against TK-Varicella zoster virus (07/1 strain) | ChEMBL. | 7932543 |
MIC (functional) | > 50 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells against Cytomegalovirus virus (Davis strain) | ChEMBL. | 7932543 |
MIC (functional) | > 50 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells against Cytomegalovirus virus (AD-169 strain) | ChEMBL. | 7932543 |
MIC (functional) | > 100 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells for morphological alteration | ChEMBL. | 7932543 |
MIC (functional) | > 100 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells for morphological alteration | ChEMBL. | 7932543 |
MIC (functional) | > 120 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against TK+/TK-Herpes simplex virus type 1 (VMW1837 strain) | ChEMBL. | 7932543 |
MIC (functional) | > 150 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against Vaccinia virus | ChEMBL. | 7932543 |
MIC (functional) | > 175 ug ml-1 | The minimum inhibitory concentration was measured on E6SM cells against Vesicular stomatitis virus | ChEMBL. | 7932543 |
MIC (functional) | > 200 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells in cell growth | ChEMBL. | 7932543 |
MIC (functional) | > 200 ug ml-1 | The minimum inhibitory concentration was measured on HEL cells in cell growth | ChEMBL. | 7932543 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.